Yahoo Search Busca da Web

Resultado da Busca

  1. 30 de abr. de 2024 · This ESMO Clinical Practice Guideline provides key recommendations for managing Merkel-cell carcinoma (MCC). Recommendations are based on available scientific data and the multidisciplinary group of experts’ collective opinion. The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.

  2. 30 de abr. de 2024 · Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.

  3. 20 de mai. de 2024 · Managing localized colorectal cancer is complicated and constantly evolving as new data emerge. Total neoadjuvant therapy using chemotherapy and radiation is effecti... Evolving Standards of Care in the Management of Localized Colorectal Cancer | American Society of Clinical Oncology Educational Book

  4. 13 de mai. de 2024 · Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110) - ESMO Open. Original research | Volume 9, ISSUE 5, 103374, May 2024.

  5. 11 de mai. de 2024 · Extending the continuum of care for metastatic colorectal cancer. 11 May 2024 Cancer Research Survivorship Targeted Therapy Colon and Rectal Cancer. While novel agents continue to enrich the therapeutic armamentarium in this setting, patients ask for a longer survival, but also for a better quality of life. The increase of ...

  6. 10 de mai. de 2024 · Treatment of colorectal cancer in older adults warrants specific considerations due to the effects of aging on comorbidities, functional and cognitive status, and socioeconomic factors.

  7. Há 4 dias · Stage II colon cancer (CC) exhibits considerable prognostic heterogeneous. Our objective was to assess survival but also the prognosis impact of microsatellite instability (MSI) in patients with stage IIC (T4bN0M0) CC.